Results 121 to 130 of about 3,991 (207)

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma. [PDF]

Oncologist
Lim M, Grandhi N, Shah P, Raghav K, Serpas V, Morelli MP, Pedersen K, Kalyan A, Salem M, Huey R, Shen JP, Wang H, Wang H, Vinocha A, Thomas J, Wolff R, Overman MJ.   +16 more
europepmc   +1 more source

Treatment Patterns and Attrition in Metastatic Castration-Resistant Prostate Cancer.

JAMA Netw Open
Hooper G, Jo Y, Nandakumar V, Gebrael G, Ozay ZI, Ostrowski M, Hardy T, Lin E, Campbell P, Murdock EG, Upadhyay L, Goel K, Thomas VM, Li H, Sokolova AO, Swami U, Agarwal N.   +16 more
europepmc   +1 more source

Acute effects of taxanes on sub-tissue fluid proportions in patients with breast cancer who underwent taxane-based chemotherapy. [PDF]

Support Care Cancer
Tuğral A, Bakar Y, Akyol M.
europepmc   +1 more source

A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer. [PDF]

Oncologist
Graff JN, Smith CEP, Sokolova AO, Qian DZ, Beer TM, Latour E, Bailey S, Kreitner D, Grivas P, Schweizer MT, Higano CS, Alumkal JJ, Vuky J, Yu EY, Cheng HH.   +14 more
europepmc   +1 more source

Pertuzumab Vs. Pyrotinib in Combination With Trastuzumab and Taxanes for First-Line Treatment of HER2+ MBC: A Multicenter Real-World Study. [PDF]

Cancer Med
Kuang M, Li J, Bian L, Zhang S, Wang T, Tong Z, Ouyang Q, Jiang Z.   +7 more
europepmc   +1 more source

Fungal endophytes of Taxus species and regulatory effect of two strains on taxol synthesis. [PDF]

BMC Microbiol
Zhang H, Lin W, Ma R, Zang Y, Hou K, Xu Z, Xi X, Zhang W, Tang S, Liang X, Sun Y, Shen C.   +11 more
europepmc   +1 more source

Association between hyperglycemia and the development of chemotherapy induced peripheral neuropathy among patients with breast cancer in the control trial. [PDF]

Breast Cancer Res
Klahr MP, Faheem K, Raghunathan RR, Wooster M, Hershman DL, Accordino MK.   +5 more
europepmc   +1 more source

The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study. [PDF]

Arch Gynecol Obstet
Eissler K, Engler T, Dannehl D, Schönfisch B, Englisch J, Hartkopf AD, Brucker SY, Grischke EM, Volmer LL, Englisch A.   +9 more
europepmc   +1 more source

Association of germline BRCA and homologous recombination deficiency with hematologic toxicity during platinum-taxane chemotherapy in ovarian cancer. [PDF]

Int J Clin Oncol
Yoshida K, Araki H, Yamada Y, Masahashi Y, Miyamoto E, Katayama K, Kubokawa M, Mogi K, Yoshihara M, Nagao Y, Tamauchi S, Yokoi A, Yoshikawa N, Niimi K, Kajiyama H.   +14 more
europepmc   +1 more source

Engineered membrane-coated nanoparticles enhance ferroptosis and microtubule inhibition in prostate cancer. [PDF]

J Mater Sci Mater Med
Yang K, Wang Y, Guo C, Zhang X, Wu J.
europepmc   +1 more source